New sedation approach may reduce breathing risks during heart valve procedure
NCT ID NCT07532733
First seen Apr 28, 2026 · Last updated May 01, 2026 · Updated 2 times
Summary
This study tests whether a sedative called dexmedetomidine causes fewer breathing problems than the standard combination of propofol and remifentanil during a minimally invasive heart valve replacement (TAVI). Researchers will monitor 80 elderly patients for oxygen drops, slow breathing, and airway issues. The goal is to find a safer sedation method for this fragile population.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TAVI(TRANSCATHETER AORTIC VALVE IMPLANTATION) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
HUB Erasme
RECRUITINGBrussels, 1070, Belgium
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.